Five centers participated in a double-blind, randomized, active-drug controlled study. The selected patients had a diagnosis of primary hypercholesterolemia (phenotype Ha or lib, total cholesterol [TC] > 300 mg/dl, low-density lipoprotein [LDL] cholesterol > 195 mg/dl, triglycerides [TG]